SCHEMBL5323151

SCHEMBL5323151

NC(=O)C1(C2CCCCC2)CCCC(O)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.34
TSHR P16473 2/20 0.34
ABCB11 O95342 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CYP2D6 P10635 1/20 0.34
CHRM1 P11229 1/20 0.34
CYP2C9 P11712 1/20 0.34
CHRM3 P20309 1/20 0.34
DRD1 P21728 1/20 0.34
HRH2 P25021 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HRH1 P35367 1/20 0.34
DRD3 P35462 1/20 0.34
SCN1A P35498 1/20 0.34
THPO P40225 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1837522 0.81
SCHEMBL29078535 0.81 CYP3A4 (0.42) CYP3A4TSHRABCB11LMNACYP1A2
SCHEMBL15579618 0.81 CYP3A4 (0.42) CYP3A4TSHRABCB11LMNACYP1A2
SCHEMBL1041208 0.81 CYP3A4 (0.39) CYP3A4TSHRABCB11LMNACYP1A2
SCHEMBL30152476 0.81 CYP3A4 (0.42) CYP3A4TSHRABCB11LMNACYP1A2
SCHEMBL3706334 0.80 CYP3A4 (0.34) CYP3A4TSHRABCB11LMNACYP1A2
Lithium SCHEMBL5448277 0.79 CYP3A4 (0.41) CYP3A4TSHRABCB11LMNACYP1A2
SCHEMBL994460 0.78 EPHX1 (0.38) CYP3A4TSHRABCB11LMNACYP1A2
SCHEMBL30152586 0.77 CYP3A4 (0.39) CYP3A4TSHRABCB11LMNACYP1A2
SCHEMBL22117116 0.75 CYP2D6 (0.32) CYP3A4TSHRABCB11LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007103719-A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME INCYTE CORPORATION (US) 2007-09-13 WO disclosed